BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37119411)

  • 21. Norcantharidin down-regulates iron contents in the liver and spleen of lipopolysaccharide-treated mice.
    Zheng J; Wang JJ; Ma HM; Shen MQ; Qian ZM; Bao YX
    Redox Rep; 2022 Dec; 27(1):119-127. PubMed ID: 35735222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic administration of 2-acetylaminofluorene alters the cellular iron metabolism in rat liver.
    Shpyleva SI; Muskhelishvili L; Tryndyak VP; Koturbash I; Tokar EJ; Waalkes MP; Beland FA; Pogribny IP
    Toxicol Sci; 2011 Oct; 123(2):433-40. PubMed ID: 21785164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepcidin/ferroportin expression levels involve efficacy of pegylated-interferon plus ribavirin in hepatitis C virus-infected liver.
    Kohjima M; Yoshimoto T; Enjoji M; Fukushima N; Fukuizumi K; Nakamura T; Kurokawa M; Fujimori N; Sasaki Y; Shimonaka Y; Murata Y; Koyama S; Kawabe K; Haraguchi K; Sumida Y; Harada N; Kato M; Kotoh K; Nakamuta M
    World J Gastroenterol; 2015 Mar; 21(11):3291-9. PubMed ID: 25805936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matriptase-2 and Hemojuvelin in Hepcidin Regulation: In Vivo Immunoblot Studies in
    Krijt J; Frýdlová J; Gurieva I; Přikryl P; Báječný M; Steinbicker AU; Vokurka M; Truksa J
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800732
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin A deficiency modulates iron metabolism independent of hemojuvelin (Hfe2) and bone morphogenetic protein 6 (Bmp6) transcript levels.
    Mendes JF; Siqueira EM; de Brito E Silva JG; Arruda SF
    Genes Nutr; 2016; 11():1. PubMed ID: 27551308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts.
    Zhang DL; Senecal T; Ghosh MC; Ollivierre-Wilson H; Tu T; Rouault TA
    Blood; 2011 Sep; 118(10):2868-77. PubMed ID: 21700773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic expression of hemochromatosis genes in two mouse strains after phlebotomy and iron overload.
    Bondi A; Valentino P; Daraio F; Porporato P; Gramaglia E; Carturan S; Gottardi E; Camaschella C; Roetto A
    Haematologica; 2005 Sep; 90(9):1161-7. PubMed ID: 16154838
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Iron homeostasis and anemia markers in early breast cancer.
    Lamy PJ; Durigova A; Jacot W
    Clin Chim Acta; 2014 Jul; 434():34-40. PubMed ID: 24768787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Iron regulatory protein 1 outcompetes iron regulatory protein 2 in regulating cellular iron homeostasis in response to nitric oxide.
    Styś A; Galy B; Starzyński RR; Smuda E; Drapier JC; Lipiński P; Bouton C
    J Biol Chem; 2011 Jul; 286(26):22846-54. PubMed ID: 21566147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gluconeogenic signals regulate iron homeostasis via hepcidin in mice.
    Vecchi C; Montosi G; Garuti C; Corradini E; Sabelli M; Canali S; Pietrangelo A
    Gastroenterology; 2014 Apr; 146(4):1060-9. PubMed ID: 24361124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver hemojuvelin protein levels in mice deficient in matriptase-2 (Tmprss6).
    Krijt J; Fujikura Y; Ramsay AJ; Velasco G; Nečas E
    Blood Cells Mol Dis; 2011 Aug; 47(2):133-7. PubMed ID: 21612955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice.
    Castoldi M; Vujic Spasic M; Altamura S; Elmén J; Lindow M; Kiss J; Stolte J; Sparla R; D'Alessandro LA; Klingmüller U; Fleming RE; Longerich T; Gröne HJ; Benes V; Kauppinen S; Hentze MW; Muckenthaler MU
    J Clin Invest; 2011 Apr; 121(4):1386-96. PubMed ID: 21364282
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies.
    Julián-Serrano S; Yuan F; Wheeler W; Benyamin B; Machiela MJ; Arslan AA; Beane-Freeman LE; Bracci PM; Duell EJ; Du M; Gallinger S; Giles GG; Goodman PJ; Kooperberg C; Marchand LL; Neale RE; Shu XO; Van Den Eeden SK; Visvanathan K; Zheng W; Albanes D; Andreotti G; Ardanaz E; Babic A; Berndt SI; Brais LK; Brennan P; Bueno-de-Mesquita B; Buring JE; Chanock SJ; Childs EJ; Chung CC; Fabiánová E; Foretová L; Fuchs CS; Gaziano JM; Gentiluomo M; Giovannucci EL; Goggins MG; Hackert T; Hartge P; Hassan MM; Holcátová I; Holly EA; Hung RI; Janout V; Kurtz RC; Lee IM; Malats N; McKean D; Milne RL; Newton CC; Oberg AL; Perdomo S; Peters U; Porta M; Rothman N; Schulze MB; Sesso HD; Silverman DT; Thompson IM; Wactawski-Wende J; Weiderpass E; Wenstzensen N; White E; Wilkens LR; Yu H; Zeleniuch-Jacquotte A; Zhong J; Kraft P; Li D; Campbell PT; Petersen GM; Wolpin BM; Risch HA; Amundadottir LT; Klein AP; Yu K; Stolzenberg-Solomon RZ
    Am J Clin Nutr; 2021 Oct; 114(4):1408-1417. PubMed ID: 34258619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic Variations of ferroportin-1(FPN1-8CG), TMPRSS6 (rs855791) and Hemojuvelin (I222N and G320V) Among a Cohort of Egyptian β-Thalassemia Major Patients.
    El-Gharbawi N; Shaheen I; Hamdy M; Elgawhary S; Samir M; Hanna BM; Ali EY; Youssef EA
    Indian J Hematol Blood Transfus; 2023 Apr; 39(2):258-265. PubMed ID: 37006987
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis.
    Meyron-Holtz EG; Ghosh MC; Iwai K; LaVaute T; Brazzolotto X; Berger UV; Land W; Ollivierre-Wilson H; Grinberg A; Love P; Rouault TA
    EMBO J; 2004 Jan; 23(2):386-95. PubMed ID: 14726953
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An iron regulatory gene signature predicts outcome in breast cancer.
    Miller LD; Coffman LG; Chou JW; Black MA; Bergh J; D'Agostino R; Torti SV; Torti FM
    Cancer Res; 2011 Nov; 71(21):6728-37. PubMed ID: 21875943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
    Yang DC; Wang F; Elliott RL; Head JF
    Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disordered hepcidin-ferroportin signaling promotes breast cancer growth.
    Zhang S; Chen Y; Guo W; Yuan L; Zhang D; Xu Y; Nemeth E; Ganz T; Liu S
    Cell Signal; 2014 Nov; 26(11):2539-50. PubMed ID: 25093806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron.
    Melis MA; Cau M; Congiu R; Sole G; Barella S; Cao A; Westerman M; Cazzola M; Galanello R
    Haematologica; 2008 Oct; 93(10):1473-9. PubMed ID: 18603562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of ferritin alterations in human breast cancer cells.
    Shpyleva SI; Tryndyak VP; Kovalchuk O; Starlard-Davenport A; Chekhun VF; Beland FA; Pogribny IP
    Breast Cancer Res Treat; 2011 Feb; 126(1):63-71. PubMed ID: 20390345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.